Susquehanna International Group
IGC icon

Susquehanna International Group’s IGC Pharma IGC Stock Holding History

Susquehanna International Group’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,600
Closed -$2.97K – 12691
2023
Q4 		$2.97K Sell
10,600
-6,200
-37% -$1.92K ﹤0.01% 12154
2023
Q3 		$6.05K Buy
16,800
+800
+5% +$286 ﹤0.01% 11765
2023
Q2 		$4.96K Hold
16,000
– – ﹤0.01% 11831
2023
Q1 		$5.44K Sell
16,000
-1,200
-7% -$450 ﹤0.01% 12299
2022
Q4 		$5.5K Sell
17,200
-37,800
-69% -$15.4K ﹤0.01% 12027
2022
Q3 		$24K Buy
55,000
+1,000
+2% +$533 ﹤0.01% 12529
2022
Q2 		$29K Sell
54,000
-1,400
-3% -$883 ﹤0.01% 12235
2022
Q1 		$53K Sell
55,400
-56,300
-50% -$54.7K ﹤0.01% 12285
2021
Q4 		$109K Sell
111,700
-99,700
-47% -$134K ﹤0.01% 12081
2021
Q3 		$313K Buy
211,400
+48,900
+30% +$79.1K ﹤0.01% 10507
2021
Q2 		$267K Sell
162,500
-185,000
-53% -$282K ﹤0.01% 11026
2021
Q1 		$622K Buy
347,500
+174,100
+100% +$316K ﹤0.01% 8960
2020
Q4 		$271K Buy
173,400
+47,000
+37% +$69.5K ﹤0.01% 9472
2020
Q3 		$131K Buy
+126,400
New +$128K ﹤0.01% 9772
2019
Q4 		– Sell
-22,400
Closed -$22K – 10117
2019
Q3 		$22K Buy
22,400
+8,200
+58% +$9.87K ﹤0.01% 9938
2019
Q2 		$23K Sell
14,200
-7,800
-35% -$11K ﹤0.01% 9990
2019
Q1 		$46K Buy
+22,000
New +$50K ﹤0.01% 8479

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Susquehanna International Group's IGC Position: Q1 2026 in Review

Susquehanna International Group reduced its IGC Pharma (IGC) stake by 21% in Q1 2026, selling an estimated $8.98K and leaving 122,595 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12748.

Susquehanna International Group first reported a position in IGC in Q1 2016 and has held it in 26 quarters since. The position peaked at $878K in Q1 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Susquehanna International Group held 122,595 shares of IGC Pharma worth $32.2K as of Q1 2026.
  • Susquehanna International Group sold 32,364 IGC Pharma shares in Q1 2026, an estimated $8.98K.
  • IGC Pharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12748 holding.
  • Susquehanna International Group first reported a position in IGC Pharma in Q1 2016 and has held it in 26 quarters since.
  • Susquehanna International Group's IGC Pharma position peaked at $878K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.